Dexcom (DXCM) Change in Acquisitions & Divestments (2010 - 2026)

Dexcom (DXCM) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $468.2 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 27.99% year-over-year to $468.2 million in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 15.73% decrease from a year earlier, with the FY2025 full-year figure at $2.2 billion, down 23.36% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $468.2 million, up from $409.6 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for DXCM reached as high as $1.1 billion in Q1 2024 and fell as low as $241.8 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $619.6 million across 5 years, with a median of $638.7 million in 2025.
• Across the five-year window, Change in Acquisitions & Divestments slumped 69.39% in 2022 and jumped 188.5% in 2023, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $740.0 million in 2022, then declined by 2.84% to $719.0 million in 2023, then slumped by 43.64% to $405.2 million in 2024, then rose by 1.09% to $409.6 million in 2025, then climbed by 14.31% to $468.2 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $468.2 million in Q1 2026, $409.6 million in Q4 2025, and $466.2 million in Q3 2025.